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Authors’ response
We appreciate the comments and interest from 
Balta et al. [1] on our study “A prospective study 
about impact of renal dysfunction and morbidity and 
mortality on cardiovascular events after ischemic 
stroke” published in “Cardiology Journal” [2].
We agree that there are many risk factors that 
predict cardiovascular (CV) events and mortality 
in patients after ischemic stroke. Results of our 
study showed that also renal dysfunction is an 
independent risk factor for CV mortality after is-
chemic stroke. In our study, several cofactors were 
analyzed however, anemia was not a co-factor under 
investigation, yet we agree that further studies on 
this topic should be done.
At the time our study was designed the Mo-
dification of Diet in Renal Disease (MDRD) study 
equation was the most widely used formula in 
clinical practice [3]. Moreover, the MDRD study 
equation was widely applied and evaluated in nu-
merous previously published studies. However, 
regarding new guidelines for evaluation of patients 
with renal dysfunction, which emphasize the use of 
more accurate glomerular filtration rate equations, 
further studies with use of the new creatinine-
-based (Chronic Kidney Disease Epidemiology 
Collaboration — CKD-EPI) equation for estimating 
renal dysfunction on further CV events and CV 
mortality in patients after ischemic stroke should 
be undertaken [4].
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